The FINANCIAL — Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced on August 3 that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback